ARROWHEAD PHARMACEUTICALS, INC.: capex
| Value | {"amount": 10067000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2019-10-01 – 2020-06-30 |
| Status | current |
| Entity | ARROWHEAD PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:45:39.303906+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b2d2575d-9007-46a2-9373-9d6719d08588
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-041593 · Open the official SEC filing →Retrieved: 2026-08-19T08:45:39.303906+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000879407/capex/2020-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b2d2575d-9007-46a2-9373-9d6719d08588
History
- supersedes {"amount": 10067360, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001564590-20-036812)